Download PDF
1 / Pages

Other users also viewed these articles

Relapsed malignant pleural mesothelioma: An impressive response to Nivolumab monotherapy S. Costa-Martins; I. Vicente; S. Valente;
Pulmonol. 2022;28:142-4
Cost-effectiveness of omalizumab in real world uncontrolled allergic asthma patients A. Arrobas; M.P. Barbosa; S. Rabiais; B. Vandewalle; J. FĂ©lix;
Pulmonol. 2021;27:124-33